Your browser doesn't support javascript.
loading
Cyclophosphamide-Mediated Tumor Priming for Enhanced Delivery and Antitumor Activity of HER2-Targeted Liposomal Doxorubicin (MM-302).
Geretti, Elena; Leonard, Shannon Curtis; Dumont, Nancy; Lee, Helen; Zheng, Jinzi; De Souza, Raquel; Gaddy, Daniel F; Espelin, Christopher W; Jaffray, David A; Moyo, Victor; Nielsen, Ulrik B; Wickham, Thomas J; Hendriks, Bart S.
Afiliação
  • Geretti E; Merrimack Pharmaceuticals, Cambridge, Massachusetts. egeretti@merrimackpharma.com.
  • Leonard SC; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Dumont N; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Lee H; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Zheng J; STTARR, Spatio-Temporal Targeting and Amplification of Radiation Response Program, Toronto, Ontario, Canada.
  • De Souza R; STTARR, Spatio-Temporal Targeting and Amplification of Radiation Response Program, Toronto, Ontario, Canada.
  • Gaddy DF; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Espelin CW; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Jaffray DA; STTARR, Spatio-Temporal Targeting and Amplification of Radiation Response Program, Toronto, Ontario, Canada.
  • Moyo V; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Nielsen UB; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Wickham TJ; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
  • Hendriks BS; Merrimack Pharmaceuticals, Cambridge, Massachusetts.
Mol Cancer Ther ; 14(9): 2060-71, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26162690
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doxorrubicina / Receptor ErbB-2 / Ciclofosfamida / Antibióticos Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doxorrubicina / Receptor ErbB-2 / Ciclofosfamida / Antibióticos Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article